1D8N-CEGa1

N/A

Report date: 2024/11/18 10:03:35

Base Information

Drug Name1D8N-CEGa1
Drug Alias Name1D8N/CEGa11D8N-CEGa1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 9 agonistsEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1Tumor necrosis factor receptor superfamily member 9
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLeadartis SL
China Registration ClassN/A

Develop Information

Active CompaniesLeadartis SL
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A